Corcept Therapeutics
CORT
119.60
+0.03
+0.03%
Corcept Therapeutics
US · CORT
#1285 by market cap
Listed 1970
119.60
+0.03
+0.03%
Live - 5344 symbols - heartbeat 12s ago
· 2026-10-08 06:36
Pre-market
120.67
+0.89%
After-hours
119.60
0.00%
- Market cap
- 12.93B
- P/E (TTM)i
- 265.78
- P/Bi
- 18.32
- EPSi
- 0.82
- Div yieldi
- 0.00%
- 52W posi
- 93%
Reader sentiment
Are you bullish or bearish on CORT?
Anonymous reader poll. Unscientific, not investment advice.
About Corcept Therapeutics
Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.
- Founded
- 1998
- CEO
- Dr. Joseph K. Belanoff, M.D.
- Employees
- 730
- Headquarters
- Redwood City, California, United States of America
- Fiscal year end
- 12-31
- Website
- corcept.com
Company profile
- Exchange
- US
- Symbol
- CORT
- Market-cap rank
- #1285
- Listing date
- 1970-01-01
- Market cap
- 12.93B
- Float cap
- 11.54B
- Shares out
- 108.10M
- Float shares
- 96.48M
Sectors & themes
Quote time 2026-10-08 06:36:38 · For reference only, not investment advice and not tailored to your situation.